Correlation Between Achilles Therapeutics and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Senti Biosciences, you can compare the effects of market volatilities on Achilles Therapeutics and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Senti Biosciences.
Diversification Opportunities for Achilles Therapeutics and Senti Biosciences
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Achilles and Senti is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Senti Biosciences go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Senti Biosciences
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.53 times more return on investment than Senti Biosciences. However, Achilles Therapeutics PLC is 1.88 times less risky than Senti Biosciences. It trades about -0.01 of its potential returns per unit of risk. Senti Biosciences is currently generating about -0.03 per unit of risk. If you would invest 175.00 in Achilles Therapeutics PLC on August 23, 2024 and sell it today you would lose (68.00) from holding Achilles Therapeutics PLC or give up 38.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Senti Biosciences
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Senti Biosciences |
Achilles Therapeutics and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Senti Biosciences
The main advantage of trading using opposite Achilles Therapeutics and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |